Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
COVID-19 Vaccine Rush Pushes Biotech Deals
For the past few weeks, we’ve discussed the widening effects of the current pandemic on healthcare M&A, particularly on the services sectors, but until this week, dealmaking hasn’t been directly focused on COVID-19. As the biotechnology and pharmaceutical industries race to find a COVID-19 vaccine, companies are bolstering their efforts with new collaborations and acquisitions. They’re the first transactions of their kind, and we expect to see more in the coming months. This week, Novavax, Inc. (NASDAQ: NVAX), a clinical-stage company focused on developing recombinant protein nanoparticle vaccines, spent $167 million cash to acquire Praha Vaccines from Cyrus... Read More »
Private Equity Still Driving Behavioral Health Deals
As healthcare M&A deal volume drops, particularly in the services sectors, behavioral health targets are still in hot demand, especially for private equity firms. Roughly 18% of deals announced by a PE buyer in the second quarter have targeted companies in the Behavioral Health Care sector, the highest concentration for any of the healthcare sectors. That statistic certainly correlates with the spike in demand for mental health services triggered by the anxiety surrounding COVID-19, as outlined in this article from The Chartis Group, an advisory and analytics services firm focused on the healthcare industry. Additionally, in early March, the U.S Centers for Medicare & Medicaid... Read More »
Health Care M&A Deals, May 29, 2020
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our Deal Search Online database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. This week’s top deals include a Gilead Sciences’ and Arcus Biosciences’ collaboration agreement on cancer immunotherapies for $175 million and Novavax, Inc.’s acquisition of Praha Vaccines for $167 million. To subscribe to our Health Care M&A deals chart and more, visit our membership site. HealthCareMandA.com is devoted to healthcare merger and acquisition... Read More »
REIT Deals are Still Closing Despite COVID-19
Despite COVID-19 taking a hit on REIT stocks and earnings, especially in the senior care industry, some buyers managed to close deals in May, primarily for medical office buildings. This might come as a surprise since physician practices are getting hit especially hard by COVID-19, so these deals may have been in the works before the pandemic crashed into the economy, or real estate values are running cheap. Just this week, Anchor Health Properties, a full-service real estate development, management, and investment company focused on healthcare property, announced its purchase of the Walther Professional Center, an 18,471-square-foot medical office building located close to Northside... Read More »
Health Care M&A Deals, May 22, 2020
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our Deal Search Online database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. This week’s top deals include Omada Health’s acquisitions of Physera, Inc. for $37 million and Induction Healthcare Group PLC ‘s purchase of Zesty $15.56 million. To subscribe to our Health Care M&A deals chart and more, visit our membership site. HealthCareMandA.com is devoted to healthcare merger and acquisition data for the... Read More »
WELL Health Boosts Digital Health Portfolio
WELL Health Technologies Corp. (TSX.V: WELL) has added another digital health firm to its growing portfolio. This week, the Canadian company announced it is acquiring Indivica, Inc. for $4.47 million (CA$6.2 million), consisting of CA$3.41 million in cash upon closing; CA$1.55 million in WELL common shares and a time-based earn-out of CA$1.24 million paid within 120 days of closing. Indivica provides fully hosted electronic medical record (EMR) software and services to more than 390 clinics serving more than 2,000 physicians and medical practitioners in Ontario. On a trailing 12-month basis, Indivica generated approximately US$1.3 million in total revenue, the vast majority from recurring... Read More »
NaviHealth Changes Owners – Again
The merry-go-round of owners may finally be slowing for naviHealth, a digital healthcare company that helps health systems and insurers manage post-acute care bundled payments. In its third change of command, naviHealth is now part of OptumHealth, which is part of the Optum division of UnitedHealth (NYSE: UNH). It now manages post-acute services for 4.5 million Medicare Advantage members and nine of the top 10 health systems. NaviHealth was founded in 2012 by Tom Scully, former administrator for the Centers for Medicare and Medicaid Services (CMS), who joined Welsh, Carson, Anderson & Stowe in 2004. In August 2015, WCAS sold a 71% stake in the company to Cardinal Health (NYSE: CAH) for... Read More »
Omada Health Adds Physera
Omada Health, a digital health coaching company based in San Francisco, didn’t have to go far to find a perfect target. On May 19, the company announced its acquisition of Physera, Inc., a digital physical therapy provider also based in San Francisco. In conjunction with the acquisition, Omada raised an additional round of growth capital from Perceptive Advisors, a life sciences investment firm, to finance the deal and support future growth. CNN reported that $37 million of that investment went to the Physera acquisition. Physera is a musculoskeletal care company that delivers physical therapy and interventions digitally and via telehealth visits to achieve clinical outcomes and... Read More »
Change Healthcare Lives Up to its Name
This is an eventful year for Change Healthcare (NASDAQ: CHNG). Not only did it split from longtime partner McKesson Corporation (NYSE: MCK) in March, it bought and sold some companies in May. First, the split with McKesson. Back in June 2016, McKesson acquired a 70% stake in Change Healthcare, then backed by Blackstone Group and Hellman & Friedman. At the time, Change provided software, analytics, and network solutions aimed to give users more effective communications, payments, and actionable insights. The merger combined substantially all of Change Healthcare’s business and the majority of McKesson’s Technology Solutions into a new company, still called Change Healthcare.... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
